Patches for improving gastrointestinal absorption: an overview.

The oral route is probably the preferred method for drug administration, owing to simplicity and positive safety aspects. Despite these advantages, this route of administration presents limitations relating to difficult absorption for some molecules, such as peptides, proteins and nucleic acids. Numerous approaches have been proposed to circumvent this drawback and improve the absorption of these active substances, but today, these approaches are often inefficient. Therefore, the use of patches for oral delivery was proposed, realized by using traditional techniques or microfabrication procedures. This review will focus on the rationale underlying the development of these dosage forms, critically discussing their performance and potential.

[1]  Jong Suk Lee,et al.  Preparation and characterization of coenzyme Q10-loaded PMMA nanoparticles by a new emulsification process based on microfluidization , 2002 .

[2]  P. McCarron,et al.  Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. , 2007, Journal of photochemistry and photobiology. B, Biology.

[3]  F. Martin,et al.  Microfabricated Drug Delivery Systems: Concepts to Improve Clinical Benefit , 2001 .

[4]  Pei Li,et al.  Amine-containing core-shell nanoparticles as potential drug carriers for intracellular delivery. , 2007, Journal of biomedical materials research. Part A.

[5]  Ick Chan Kwon,et al.  Oral protein delivery: Current status and future prospect , 2011 .

[6]  N. Shibata,et al.  Absorption of interferon alpha from patches in rats , 2005, Journal of drug targeting.

[7]  A. Bernkop‐Schnürch,et al.  Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers. , 2008, International journal of pharmaceutics.

[8]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[9]  A. Fasano Novel approaches for oral delivery of macromolecules. , 1998, Journal of pharmaceutical sciences.

[10]  Xiaoyun Wang,et al.  N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery , 2009, Drug development and industrial pharmacy.

[11]  N. Shibata,et al.  Evaluation of gastrointestinal transit characteristics of oral patch preparation using caffeine as a model drug in human volunteers. , 2002, Drug metabolism and pharmacokinetics.

[12]  A. Bernkop‐Schnürch Oral Delivery of Macromolecular Drugs , 2009 .

[13]  A. Bernkop‐Schnürch,et al.  Design and in vivo evaluation of a patch system based on thiolated polymers. , 2009, Journal of pharmaceutical sciences.

[14]  T. Desai,et al.  Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[15]  A. Lowman,et al.  Enhanced Mucoadhesive Capacity of Novel Co-polymers for Oral Protein Delivery , 2011, Journal of biomaterials science. Polymer edition.

[16]  Samir Mitragotri,et al.  Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Lichen Yin,et al.  Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. , 2009, Biomaterials.

[18]  Hongyan He,et al.  Design of a novel hydrogel-based intelligent system for controlled drug release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[19]  S. Yamashita,et al.  Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract , 1997 .

[20]  R. Panchagnula,et al.  Peroral route: an opportunity for protein and peptide drug delivery. , 2001, Chemical reviews.

[21]  Ming Lei,et al.  Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. , 2004, Advanced drug delivery reviews.

[22]  J. H. Price,et al.  Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. , 2005, International journal of pharmaceutics.

[23]  N. Shibata,et al.  Possibility of a patch system as a new oral delivery system. , 2003, International journal of pharmaceutics.

[24]  I. Toth,et al.  Co-polymerised peptide particles (CPP) I: synthesis, characterisation and in vitro studies on a novel oral nanoparticulate delivery system , 1996 .

[25]  A. Bernkop‐Schnürch Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. , 2000, International journal of pharmaceutics.

[26]  David S. Jones,et al.  Mucoadhesive polymeric platforms for controlled drug delivery. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  M. Cima,et al.  Oral dosage forms fabricated by three dimensional printing. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[28]  R. Gurny,et al.  Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. , 1998, Advanced drug delivery reviews.

[29]  G. Robillard,et al.  Use of hydrophobins in formulation of water insoluble drugs for oral administration. , 2010, Colloids and surfaces. B, Biointerfaces.

[30]  N. Peppas,et al.  Is the oral route possible for peptide and protein drug delivery? , 2006, Drug discovery today.

[31]  A. Bernkop‐Schnürch,et al.  Chemically modified chitosans as enzyme inhibitors. , 2001, Advanced drug delivery reviews.

[32]  T. Desai,et al.  Bioadhesive Microdevices for Drug Delivery: A Feasibility Study , 2001 .

[33]  S. Akhtar Oral delivery of siRNA and antisense oligonucleotides , 2009, Journal of drug targeting.

[34]  A. Bernkop‐Schnürch The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[35]  J. Irache,et al.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[36]  N. Hosten,et al.  Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging , 2005, Alimentary pharmacology & therapeutics.

[37]  Jaedeok Yoo,et al.  Development of Near Zero-Order Release Dosage Forms Using Three-Dimensional Printing (3-DP™) Technology , 2006, Drug development and industrial pharmacy.

[38]  N. Shibata,et al.  Gastro-intestinal patch system for the delivery of erythropoietin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[39]  João F Pinto,et al.  Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. , 2010, International journal of pharmaceutics.

[40]  A. Bernkop‐Schnürch,et al.  Synthesis and in vitro evaluation of a novel thiolated chitosan. , 2005, Biomaterials.

[41]  Sung Geun Kim,et al.  Fabrication of Bio-Composite Drug Delivery System Using Rapid Prototyping Technology , 2007 .

[42]  N. Shibata,et al.  Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein. , 2002, Biomaterials.

[43]  K. W. Taylor,et al.  Aqueous acidic degradation of the carbacephalosporin loracarbef. , 1993, Journal of pharmaceutical sciences.

[44]  Tejal A Desai,et al.  Gastrointestinal patch systems for oral drug delivery. , 2005, Drug discovery today.

[45]  S. Davis,et al.  In vitro evaluation of the mucoadhesive properties of chitosan microspheres , 1998 .

[46]  L. Patton,et al.  New developments and opportunities in oral mucosal drug delivery for local and systemic disease. , 2012, Advanced drug delivery reviews.

[47]  N. Shibata,et al.  Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs. , 2006, International journal of pharmaceutics.

[48]  R Langer,et al.  Microchips as Controlled Drug-Delivery Devices. , 2000, Angewandte Chemie.

[49]  Kristy M Ainslie,et al.  Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics. , 2008, Lab on a chip.

[50]  Samir Mitragotri,et al.  Intestinal Patches for Oral Drug Delivery , 2002, Pharmaceutical Research.

[51]  F. Vrečer,et al.  Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. , 2002, International journal of pharmaceutics.

[52]  Tejal A Desai,et al.  Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[53]  T. Desai,et al.  Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Kristy M Ainslie,et al.  Microfabricated devices for enhanced bioadhesive drug delivery: attachment to and small-molecule release through a cell monolayer under flow. , 2009, Small.

[55]  Jie Kong,et al.  A Facile Method to Prepare Hydrophobic Nanoparticle Dispersions for Controlled Release , 2007 .

[56]  Emanuel M. Sachs,et al.  Solid free-form fabrication of drug delivery devices , 1996 .

[57]  B. Aungst Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. , 1993, Journal of pharmaceutical sciences.